ReportWire

Tag: Medical marijuana

  • Florida bill would make medical marijuana certifications good for two years

    [ad_1]

    Credit: Shutterstock

    Florida medical marijuana patients, now required to have a physician certify that they are qualified to remain in the state’s prescription program about every seven months, would have that requirement relaxed to just once every two years under a bill introduced by a Republican lawmaker last week.

    The legislation (SB 1032) by Sen. Alexis Calatayud, R-Miami, also would allow doctors to significantly increase the supply limits that qualified doctors can prescribe to patients. The bill would allow doctors to issue certifications for up to 10 70-day supply limits of smokeable medical marijuana, rather than three. Doctors could also issue up to 20 35-day supply limits instead of the existing six.

    The proposal would waive the $75 registration and annual renewal fees to receive a medical marijuana ID card for any military veteran honorably discharged from the U.S. armed forces.

    A similar measure (HB 719) was filed in the House last month by Rep. Bill Partington, R-Ormond Beach. His bill would go further by requiring the Florida Department of Health to establish reciprocity agreements allowing patients from other states to qualify for a registration card “within 1 business day.”

    Partington’s bill also would allow doctors to recommend medical cannabis via telehealth visits for initial consultations. Existing Florida law allows telehealth visits only when patients have their cards renewed.

    There are 929,655 medical marijuana patients in Florida, according to the Office of Medical Marijuana Use. To remain in the program, each patient must renew his or her ID card with the state every 12 months at $75 per clip. They must renew certification by their doctors every 210 days, or approximately seven months from the date the physician certifies. Those fees vary by clinic and location across the state, generally ranging between $100 to $200.


    Subscribe to Orlando Weekly newsletters.

    Follow us: Apple News | Google News | NewsBreak | Reddit | Instagram | Facebook Bluesky | Or sign up for our RSS Feed


    DeSantis stayed quiet in the first days following the operation — even though Florida boasts the largest Venezuelan community in the nation

    The ruling on assisted reproduction methods raises a new complication for couples seeking to have kids with outside help

    Uthmeier and two major business groups argue the Florida amendment is misleading and conflicts with federal law



    [ad_2]

    Mitch Perry, Florida Phoenix
    Source link
  • Schaumburg family fights to keep access to daughter’s medical marijuana patches

    [ad_1]

    ByABC7 Chicago Digital Team

    Friday, January 2, 2026 4:28AM

    Local family fights to keep access to daughter's medical marijuana

    SCHAUMBURG, Ill. (WLS) — A Schaumburg family is launching a campaign to allow medical marijuana to be delivered over state lines.

    They say their daughter’s health depends on it.

    ABC7 Chicago is now streaming 24/7. Click here to watch

    Ashley Surin inspired Ashley’s Law, which gave her access to medical marijuana patches in school.

    Her parents say the patches kept her seizure-free for the last eight years.

    But the company that makes the patches has moved production out of state. And current law does not allow the patches to be shipped to Illinois.

    ABC7 reached out to lawmakers for comment but did not immediately hear back.

    Copyright © 2026 WLS-TV. All Rights Reserved.

    [ad_2]

    WLS

    Source link

  • What Does the Public Think About Rescheduling Cannabis

    [ad_1]

    What does the public think about rescheduling cannabis in a post-prohibition era driven by data, not stigma.

    What does the public think about rescheduling cannabis? Long before federal officials formally moved to reschedule cannabis, they  had already made up their mind. According to a widely cited poll from Pew Research Center, 88% of Americans supported legal cannabis in some form—either for medical use, adult use, or both—prior to the rescheduling announcement. The overwhelming consensus set the stage for what many see as a long-overdue policy shift catching up with reality.

    RELATED: 5 Ways Microdosing Cannabis Can Boost Work Performance

    Post-rescheduling polling shows public opinion has only grown more confident, particularly around cannabis’s medical potential. A December 2025 survey from YouGov found more than three-quarters of U.S. adults believe cannabis has legitimate medical uses, while just a small minority disagreed. Notably, the poll also showed broad approval for rescheduling specifically because it allows expanded medical research—an issue which resonates across party lines.

    Another YouGov medical-focused poll reinforces the point. Large majorities said cannabis should be studied and made available as a treatment option, especially where conventional therapies fall short. This is not abstract support; it reflects lived experience. Veterans coping with PTSD consistently report medical cannabis can help manage anxiety, nightmares, and sleep disruption when traditional medications fail or cause harsh side effects. For many, rescheduling represents validation rather than experimentation.

    Patients with cancer, IBS, and chronic pain echo similar sentiments. Poll respondents frequently cite cannabis’s ability to ease nausea from chemotherapy, stimulate appetite, reduce inflammation, and improve sleep quality. Sleep, in particular, stands out as a near-universal concern—one where many Americans say cannabis has helped them fall asleep faster and stay asleep longer.

    RELATED: There’s No Known Cure For Arthritis, But Marijuana Works Wonders

    The impact extends beyond people. Everyday pet owners increasingly report using CBD products to calm anxious dogs during fireworks, ease joint pain in aging pets, and improve overall quality of life. While veterinarians urge careful dosing and further study, public acceptance of pet-focused CBD mirrors the broader shift toward viewing cannabis as a wellness tool rather than a cultural wedge issue.

    Taken together, these polls paint a clear picture. Americans are not debating whether cannabis belongs in modern medicine—they are asking how best to regulate, research, and responsibly use it. Rescheduling did not change public opinion; it aligned federal policy with a public already convinced cannabis can help real people, and even their pets, live better lives.

    [ad_2]

    Anthony Washington

    Source link

  • Feds Reveal Medical Cannabis Is Very Popular With The Disabled

    [ad_1]

    Feds reveal medical cannabis is very popular with the disabled, according to a new federal study examining pain relief, access and policy implications.

    In a move displaying the practical use of marijuana, the feds reveal medical cannabis is very popular with the disabled for a sound reason. A newly released federal study finds  Americans living with disabilities are increasingly using cannabis to manage pain, stress and other chronic symptoms, underscoring a growing gap between patient behavior and federal drug policy.

    The research, published in the Disability and Health Journal and funded by the National Institute on Disability, Independent Living, and Rehabilitation Research, draws on data from nearly 2,000 adults who self-identify as having a disability. About 22 percent of respondents reported current cannabis use, a rate notably higher than estimates for the general adult population.

    RELATED: 5 Ways Microdosing Cannabis Can Boost Work Performance

    Pain relief was the most frequently cited reason for use. More than 70 percent of participants said they use cannabis to manage pain, while roughly 60 percent reported using it to relax or reduce tension. Others cited relief from migraines, nausea, muscle spasms, sleep disturbances, seizures and mental health symptoms. Participants represented a wide range of disability types, including mobility, cognitive, vision, hearing, self-care and independent living limitations.

    Researchers note the data is self-reported and not nationally representative, with respondents skewing toward white, female and college-educated individuals. Still, the authors concluded cannabis use is prevalent across disability categories and warrants greater attention from public-health officials and policymakers.

    The findings arrive as the administration weighs whether to follow through on plans to reschedule cannabis under the Controlled Substances Act. Marijuana is currently classified as a Schedule I substance, a category reserved for drugs with no accepted medical use, despite growing evidence and widespread patient use. Moving cannabis to Schedule III would formally acknowledge its medical value and reduce barriers to research.

    For patients with disabilities, rescheduling is not an abstract policy issue. Federal classification affects everything from clinical research and physician guidance to affordability and access. Because cannabis remains federally restricted, doctors often lack clear guidelines, large-scale clinical trials remain limited, and insurance coverage is nonexistent. Patients are left navigating a patchwork of state rules while managing complex health needs.

    Advocates say the study highlights how policy has lagged behind reality. Millions of Americans with chronic conditions are already using cannabis as part of their care, often after conventional treatments failed or caused severe side effects. Many report turning to cannabis to reduce reliance on opioids, muscle relaxants and sleep medications, which can carry significant risks with long-term use.

    RELATED: There’s No Known Cure For Arthritis, But Marijuana Works Wonders

    Public-health experts warn continued delay has consequences. Without expanded research and standardized medical guidance, patients rely on trial and error rather than evidence-based care. For people with disabilities, who frequently manage multiple conditions at once, the uncertainty can be particularly harmful.

    Rescheduling would not legalize cannabis nationwide, but it would ease research restrictions, encourage clinical studies focused on disability-related conditions, and provide clearer guardrails for physicians and patients alike. Supporters argue it would move cannabis use out of the shadows and into a more accountable medical framework.

    As federal officials debate next steps, the study adds urgency to the discussion. For people living with daily pain and functional limitations, cannabis is not about recreation. It is about relief. The question now is whether federal policy will catch up with the patients already depending on it.

    [ad_2]

    Amy Hansen

    Source link

  • Cannabis Businesses Just Got Their Biggest Federal Win From Trump

    [ad_1]

    President Donald Trump signed an executive order on Thursday relaxing cannabis’ classification in a change that is expected to catalyze investment and spark new innovation in an industry that’s waited decades for the very decision. 

    Trump’s executive order reschedules cannabis from Schedule I—a status it’s held for decades alongside heroin and LSD—to Schedule III, or substances like ketamine and certain steroids that are recognized for having medical benefits alongside a potential for abuse.. 

    To be clear, the executive order does not legalize cannabis, which remains illegal at the federal level. “I want to emphasize that the order I am about to sign doesn’t legalize marijuana in any way, shape, or form,” Trump said on Thursday. “In no way it sanctions its use as a recreational drug – it has nothing to do with it – just as prescription painkillers may have legitimate uses, but can also do irreversible damage.”

    The president also greenlit a program that will reimburse Medicare patients who use products containing CBD, a compound derived from cannabis plants without the psychoactive component responsible for intoxication.

    The move also opens up new opportunities in medical research since it’s far easier to conduct clinical trials on Schedule III substances compared to Schedule I drugs. The decision is also expected to expand cannabis businesses’ access to banking services in states where the substance is legal.

    “We’re grateful to President Trump for recognizing the overwhelming majority of Americans who support cannabis rescheduling, opening the door to federal reform, medical research, and normalization for an industry that employs hundreds of thousands of professionals and contributes billions of dollars in taxes and economic activity every year,” says George Archos, the founder and CEO of Verano, a cannabis company.

    Cannabis companies will also no longer face a part of the tax code known as Section 280E, which bars companies working with controlled substances from receiving tax credits or deductions. Section 280E specifically applies to Schedule I and Schedule II substances, so cannabis companies could save up to millions in taxes, according to past estimates from Vicente LLP, a law firm. 

    The Biden administration floated the decision to reclassify cannabis last year, but those efforts ultimately stagnated. And it’s a decision that doesn’t have support among all Republican lawmakers. Still, reclassification is a decision that has grown in popularity amongst Americans, particularly younger ones.  A Pew Research study demonstrates that a majority of consumers under 30 back legalizing cannabis for medical and recreational use.

      

    The extended deadline for the 2026 Inc. Regionals Awards is Friday, December 19, at 11:59 p.m. PT. Apply now.

    [ad_2]

    Melissa Angell

    Source link

  • Insa dispensaries’ Central Florida cultivation complex is modern and massive

    [ad_1]

    Hang on to your leftover Halloween candy, because this installment of Live Active Cultures is likely to activate the munchies. Massachusetts-based Insa is currently one of the smaller competitors in Florida’s medical marijuana market, with only nine dispensaries — including two in Orlando — across the state. But they’ve got huge potential for expansion if and when legal adult recreational use arrives, thanks to their ginormous grow facility in Polk County. I recently drove an hour to Auburndale for a guided tour of Insa’s high-tech facility with CEO/co-founder Peter Gallagher and head grower T.J. Cummings, and came back with a buzz about Boston bud’s future in the Sunshine State.

    Insa’s Auburndale cultivation complex is easily the most modern and massive marijuana-making facility I’ve been invited to visit so far. Although unassumingly industrial from the outside, the interior resembles Willy Wonka’s candy factory, if that film had been directed by Stanley Kubrick circa 2001: A Space Odyssey. Stark white hallways and keycard-controlled security doors — which I had to don a head-to-toe clean-suit coverall before entering — lead to vast climate-controlled rooms crowded with cannabis in every stage of development, from freshly cloned sprouts to full flowers on the verge of harvest.

    Every stage of production, from trimming and packaging to making extracts and edibles, for all of Insa’s Florida stores is handled under one roof by a staff of fewer than 60, and I was struck by how the operation is so technologically advanced — with wavelength-tuned lights and computer-controlled irrigation individually nourishing thousands of plants, and Italian confectionery equipment capable of churning out 1,500 chocolate bars in four hours — yet simultaneously old-school, like the complex contraption dribbling concentrated cannabis oil into the same Ball jelly jar your grandma might use for canning fruit.

    Before it becomes a joint or a gummy, all great ganja begins with good genetics; Frank Golfieri, Insa’s Massachusetts-based director of cultivation, is an industry veteran, says Gallagher, “So he’s got a lot of connections throughout the industry that he’ll leverage to get cuts to bring in variety and newness that we might not have in our genetic stock.” One of those new strains scheduled to arrive late this month at Insa’s Florida dispensaries is Peanut Butter Crunch, an indica-dominant hybrid of Peanut Butter Gelato and Cereal Milk that proved a hit up north: “Everyone in the company went and bought the Peanut Butter Crunch from the first drop, and the next day they came back to buy more.”

    However, if you have nostalgia for vintage sativa strains (like Insa’s pre-millennial Super Lemon Haze), Cummings has some sad news: “True sativas have kind of been bred out quite a bit. It’s rare to truly find a real sativa. … Everything’s been so hybridized. It’s almost like chasing a wolf that’s going extinct.”

    Since Insa was established in Massachusetts’ recreational market before expanding south, I was curious how cultivation methods and customer tastes differ in Florida. “It’s favorable in some instances and other times, a little more difficult,” says Cummings, who heads the 14-member grow team. “I prefer growing in Massachusetts, personally. I like growing in the wintertime; it’s easier on our HVAC, easier on our flower. The cooler temperatures bring out a little bit more cooler colors, and I think a little bit more resin development, [but] you can do a little bit more in Florida to keep things more consistent across the board.”

    As far as consumption habits go, Gallagher says he’s noticed that in recreational markets, “the mix shifts towards a heavier assortment of pre-rolls,” whereas MMJ patients here “are typically a lot more price-sensitive, looking for value; as a result of that, they’re typically smarter [and] more knowledgeable on product and how to use it, and maybe more on top of the trends.”

    Consequently, concentrates are far more popular down here. “Florida definitely has a bit more of a connoisseur approach. They like their rosin carts,” says Cummings, noting that some of Insa’s solventless products have a naturally darker color due to using more mature trichomes. “Everybody’s a bit of a rosin snob in Florida, and rightfully so. It’s expensive stuff, and you really want the best of the best.”

    Insa oversized their Auburndale installation in anticipation of recreational marijuana’s eventual legalization, and intends to support any upcoming ballot measure to that effect. Until that happens, the biggest competition to Florida’s medical marijuana industry may be the gray market of hemp-derived cannabinoids unleashed by loopholes in the 2018 Federal Farm Bill. “They’re manipulating a molecule within [hemp] to make it more potent, and now we’re experimenting on the general population, which I think is unfortunate,” Gallagher says of unregulated products containing potent synthesized psychotropics like HHC. “I think you’re creating this unknown public health risk that’s potentially harming both adults and children. … We’ve been trying to do our part in educating legislators and regulators about this issue.”

    Gallagher concludes, “We’re in an interesting period in our country’s history and in our industry’s history. We try to focus on what we can control, and it’s really just putting out a quality product and serving our customers and patients as best we can.”


    Orlando’s daily dose of what matters. Subscribe to The Daily Weekly.




    [ad_2]

    Seth Kubersky
    Source link
  • Florida lawsuit over medical marijuana users owning guns paused

    [ad_1]

    The Texas case does not involve medical-marijuana patients — it stems from the discovery of a gun and drugs during an FBI raid of the home of Ali Danial Hemani as part of a criminal investigation. Hemani was charged under the law prohibiting drug users from having guns. In a document filed at the U.S. Supreme Court, the federal government said the prosecution involved Hemani’s “habitual use of marijuana.”

    But the 5th U.S. Circuit Court of Appeals ruled in favor of Hemani’s arguments that the federal law was unconstitutional as it applied in his case. The Justice Department then asked the Supreme Court to take up the issue. While the Supreme Court announced Monday it will hear the case, it is unclear when a ruling will come.

    The Florida lawsuit was filed by then-state Agriculture Commissioner Nikki Fried and medical-marijuana patients. The lawsuit said the federal prohibitions “forbid Floridians from possessing or purchasing a firearm on the sole basis that they are state-law-abiding medical marijuana patients.”

    Winsor dismissed the case in November 2022, spurring the plaintiffs to go to the 11th U.S. Circuit Court of Appeals. Agriculture Commissioner Wilton Simpson, who was elected in 2022 to succeed Fried, dropped out of the case, but it has continued with the patients as plaintiffs.

    A panel of the appeals court this year overturned Winsor’s dismissal of the case, saying the federal government “failed to meet its burden … to establish that disarming medical marijuana users is consistent with this nation’s history and tradition of firearm regulation.”

    The ruling sent the case back to Winsor for further consideration.

    [ad_2]

    Jim Saunders, News Service of Florida

    Source link

  • What To Know About Cannabis And A Brain Aneurysm

    [ad_1]

    Discover what to know about cannabis and a brain aneurysm—risks, recovery, and medical cautions.

    When celebrity Kim Kardashian recently revealed she was diagnosed with a small brain aneurysm—reportedly detected during a routine MRI and attributed by her doctors to stress—her disclosure sparked interest in a condition most people don’t know much about. A brain aneurysm is a bulging or ballooning blood vessel in the brain, which can be life-threatening if it ruptures. With growing interest around cannabis use—both medically and recreationally—it’s worth exploring what to know about cannabis and a brain aneurysm.

    RELATED: The Science Behind Cannabis And Happiness

    A brain aneurysm (sometimes called an intracranial aneurysm) occurs when a weakened area of a blood vessel in the brain bulges outward. If the aneurysm ruptures, it can lead to a major bleed called a subarachnoid hemorrhage—a medical emergency. Many aneurysms remain small and never rupture, but risk factors include high blood pressure, smoking, genetic predisposition, and possibly vascular stress. Kim Kardashian’s case underlines how even individuals with public profiles and access to healthcare can face this silent risk.

    Cannabis—or more precisely its components such as cannabidiol (CBD) and tetrahydrocannabinol (THC)—has been studied for a variety of health issues. For some conditions like chronic pain, certain forms of epilepsy, or spasticity in multiple sclerosis, cannabinoids may offer symptomatic relief. There is emerging evidence medical marijuana can improve quality of life for some patients: reducing pain, improving sleep or mood, and even decreasing reliance on opioids in certain contexts.

    In the broad sense, in jurisdictions across the U.S., many patients use it under medical supervision for conditions like migraine, nausea from chemotherapy, or chronic neuropathic pain. “Medical” use does not equate to “safe in all contexts”—especially when other serious medical issues are present.

    When it comes to brain aneurysms—particularly after diagnosis or treatment—the research raises caution flags about cannabis use:

    • Studies show people who have had an aneurysmal subarachnoid hemorrhage (a burst aneurysm), cannabis users had higher rates of delayed cerebral ischemia (DCI)—a serious complication which can lead to poor outcome. One large study found cannabis users had about a 2.7 times greater risk of DCI compared with non-users.
    • Other studies link recreational cannabis use to a higher likelihood of having an aneurysm rupture in the first place—one estimate suggested about an 18 % increased risk.
    • Research also suggests cannabis affects vascular tone, cerebral blood flow, mitochondrial function in brain cells, and may contribute to vasospasm (narrowing of blood vessels) or oxidative stress—mechanisms which are particularly concerning in someone with a vulnerable blood vessel wall.
    • One review warned even for unruptured aneurysms, if cannabis is used, individuals should be aware they may face worse outcomes should rupture occur.

    RELATED: Evidence About Burning Mouth Syndrome And Cannabinoids

    If you or someone you know has been diagnosed with a brain aneurysm (ruptured or unruptured), here are some practical steps:

    • Talk to your neurologist/neurosurgeon about cannabis use. The research suggests elevated risks in people with aneurysms who use cannabis.
    • Avoid assuming “medical use = safe.” Even if you’re using cannabis under a physician’s care, an aneurysm changes the risk profile.
    • Focus on established risk-reduction: control blood pressure, stop smoking, manage cholesterol, avoid stimulants. These traditional strategies remain foundational.
    • If you have an untreated aneurysm and are considering cannabis for medical reasons, proceed with caution.Ask your medical team about the specific size, location, treatment plan of your aneurysm and whether there are recommended restrictions.
    • After an aneurysm rupture or treatment, strongly consider abstaining or closely monitoring any cannabis use. The data indicate increased complication rates in this particular setting.

    The public disclosure by Kim Kardashian highlights how common aneurysms may be, but it also reminds us the decision to use cannabis in a medical context should be made carefully. While cannabis offers genuine medical benefits for some conditions, when a brain aneurysm is in the picture—especially one which has ruptured or is being observed—caution is warranted. Speak with a neurologist familiar with cerebrovascular risk, weigh the benefits and the unique risks, and make an informed choice rather than assuming “legal = safe.”

    [ad_2]

    Amy Hansen

    Source link

  • Unlikely allies urge Arizona to fund medical marijuana research

    [ad_1]

    Arizona is fumbling a chance to be a leader in medical marijuana science — for reasons that aren’t clear — and should follow through on funding the would-be researchers that the state’s elected officials aimed to support. That’s the takeaway from a letter to top Arizona officials signed by a variety of marijuana-related parties who, per their own admission, rarely agree on much of anything…

    [ad_2]

    TJ L’Heureux

    Source link

  • A Doctor’s Take On Cannabis And PTSD

    [ad_1]

    Millions suffer from PTSD, but the a solution still has been developed, but doctors feel medical marijuana could help

    It is estimated 3.6% of the world’s population suffers from it, so here is a doctor’s take on cannabis and PTSD. Thomas Green, MD is a retired urologists who has spent his life helping those suffering from difficult diagnosis. PTSD Isn’t just about bad memories, it can mean sleepless nights, sudden anxiety, and feeling like danger is always just around the corner. Veterans, accident survivors, first responders, anyone who’s been through trauma can live with it.

    “Some people with PTSD aren’t chasing a high,  they’re chasing a good night’s sleep.” share’s Dr. Green.

    RELATED: Female, Veggie, And What? Some Unknown Marijuana Facts

    While I was still in practice, I treated a Vietnam vet for a urologic condition. That part was easy to fix. What wasn’t easy was his disabling PTSD. Back then, cannabis wasn’t as widely discussed in medicine as it is today, but I encouraged him to talk with his doctor or check out a local dispensary to learn more. I knew it might be one more tool to help him find some peace.

    Photo by CapturedNuance/Getty Images

    Some people with PTSD say cannabis helps them fall asleep, quiets racing thoughts, and takes the edge off flashbacks. The science is still catching up, but here’s the idea: cannabis works with the body’s endocannabinoid system, the network that helps regulate mood, stress, and sleep.

    “Cannabis works with the body’s own stress-regulating system, that’s why it may help.”

    THC, the compound that can get you high, may help dull the emotional punch of painful memories. CBD, the non-intoxicating sidekick, may help with anxiety and calmness. Some people find relief with one or the other. Others use a blend.

    Is it a magic fix? No. Cannabis isn’t for everyone. High-THC products can make some people feel more anxious. The key is starting low, going slow, and, if possible, working with a healthcare provider who knows cannabis.

    RELATED: Feds More Open To Medical Marijuiana For Veterans

    Research is growing, but early signs are promising. For now, many people combine cannabis with therapy, exercise, and other healthy habits.

    “It’s not a magic fix, but for some, it’s one more tool for calmer days and better nights.”

    Bottom line: If you’re dealing with PTSD and thinking about cannabis, get advice tailored to you. For some, it’s one more tool for better sleep, calmer days, and a little peace of mind.

    [ad_2]

    Thomas Green, MD

    Source link

  • Texas Expands Access to Medical Cannabis

    [ad_1]

    Republican Gov. Greg Abbott has signed legislation into law expanding patients’ access to state-qualified medical cannabis products.

    House Bill 46 opens the Texas Compassionate Use Program to include those suffering from chronic pain, Crohn’s disease, traumatic brain injury, and other newly eligible conditions. It also expands the variety of cannabis formulations that patients may possess and significantly increases the total number of state-licensed dispensaries that can operate in the state from three to a total of fifteen.

    Under the revised law, which takes effect on September 1, 2025, patients are permitted to vaporize but not smoke cannabis. Medical cannabis products may not exceed 10 mgs of THC per dosing unit. Physicians may authorize up to a 90-day supply of medical cannabis to qualifying patients.

    According to 2025 data provided by the Texas Department of Safety, over 116,000 patients are active participants in the Compassionate Use Program. Lawmakers initially enacted legislation establishing the Compassionate Use Program in 2015 and expanded it in 2021. Following these latest expansions, NORML classifies Texas as the 40th medical cannabis state.

    Additional information about the Texas Compassionate Use Program is available from the Texas Department of Public Safety.

    [ad_2]

    NORML

    Source link

  • Nebraska AG & US Senator Urge Lawmakers To Ignore Medical Marijuana Legalization Vote

    [ad_1]

    Nebraska’s Attorney General and former Governor are urging state lawmakers to halt efforts to adopt a pair of citizen-initiated measures regulating the possession, use, and production of medical cannabis. Some 70 percent of Nebraska voters approved the measures on election day.

    Writing in an op-ed, AG Mike Hilgers and former Governor (now US Senator) Pete Ricketts called on lawmakers to ignore the voters’ will. “The legislature has no duty to act now,” they wrote. “In fact, there are plenty of reasons to not act at all.”

    The duo opined that cannabis is “harmful, easily abused, and is not safe to consume even under medical supervision.” Ricketts, a longtime opponent of marijuana policy reform, has previously alleged: “If you legalize marijuana, you’re gonna kill your kids. That’s what the data shows from around the country.”

    During public hearings yesterday, a representative from the AG’s office warned that the state would consider filing a lawsuit if regulators moved forward with licensing medical cannabis providers, arguing that such actions are inconsistent with federal law. Opponents of the law have already filed a pair of lawsuits seeking to nullify the election outcome.

    On Monday, lawmakers also heard testimony regarding legislation, LB 483, repealing patients’ access to botanical cannabis. NORML’s Deputy Director Paul Armentano provided testimony against the bill, stating: “Elections have consequences. Nebraskans have made it clear that they want patients to have regulated access to botanical cannabis. Lawmakers must respect their vote.”

    He added: “LB 483 is undemocratic; it is also bad public policy. … Many patients seeking rapid relief of symptoms such as pain, nausea, or spasticity will suffer by having their access limited solely to cannabis pills and other oral formulations,” which are far slower to take effect.

    In total, more than 300 witnesses testified against the bill.

    Lawmakers on Monday also deliberated over separate bills providing further clarity for regulating medical cannabis access. Those efforts were supported by initiative proponents Nebraskans for Medical Marijuana, who held a rally at the state capitol yesterday morning during which they criticized the former Governor’s efforts.

    “The individuals who are continuing to be opposed are absolutely disregarding the fact that 71 percent of people in this state support safe and regulated medical cannabis,” said Campaign Manager Crista Eggers. “And I would ask them to take a look at any state that has legalized medical cannabis and I’d like them to see that their arguments hold no weight.”

    Ultimately, lawmakers did not take votes yesterday on any of the marijuana-related bills.

    NORML’s Armentano warned that elected officials’ efforts in Nebraska to undermine voters’ decisions is consistent with Republican-led efforts in several other states, including Ohio, where Senate lawmakers recently voted in favor of GOP-backed legislation rescinding much of the state’s voter-approved legalization law and recriminalizing many marijuana-related activities. Separate legislation introduced earlier this year in South Dakota that sought to repeal the state’s voter-approved medical cannabis law failed by a single vote.

    “In a healthy democracy, those with competing visions on public policy vie for voters’ support and abide by their voting decisions. However, it is becoming clear that those who oppose marijuana policy reform would rather take voters out of the equation altogether,” Armentano said. “Whether or not one personally supports or opposes cannabis legalization, these cynical and undemocratic tactics ought to be a cause of deep concern.”

    A state-by-state guide to pending marijuana legislation is available from NORML’s Take Action Center.

    [ad_2]

    NORML

    Source link

  • An Alabama judge appoints a mediator in a long-running medical marijuana dispute – Cannabis Business Executive – Cannabis and Marijuana industry news

    An Alabama judge appoints a mediator in a long-running medical marijuana dispute – Cannabis Business Executive – Cannabis and Marijuana industry news

    [ad_1]





    An Alabama judge appoints a mediator in a long-running medical marijuana dispute – Cannabis Business Executive – Cannabis and Marijuana industry news




























    skip to Main Content

    [ad_2]

    AggregatedNews

    Source link

  • Tots and pot: Arizona court OKs medical dispensaries near preschools

    Tots and pot: Arizona court OKs medical dispensaries near preschools

    [ad_1]

    Medical marijuana dispensaries can operate in close proximity to preschools, the Arizona Court of Appeals ruled Thursday, reasoning that the voter-approved law legalizing medical cannabis differentiated between “schools” and “preschools.” The ruling upholds a dispensary license that the Arizona Department of Health Services awarded in 2016 for the Phoenix neighborhood of Ahwatukee…

    [ad_2]

    Jim Small | Arizona Mirror

    Source link

  • Arkansans Have A Win WIth Marijuana Ballot

    Arkansans Have A Win WIth Marijuana Ballot

    [ad_1]

    Arkansas is moving forward with increasing medical marijuana – despite the state government!

    Akansas is home to the Ozarks and to the famous Crystal Bridges Museum. It is a study of down home America and the future. Bentonville is home of Walmart, the largest physical retailer in North America. Found on their shelves is CBD from the cannabis plant. And now the citizens of the state want expanded medical marijuana. While recreational is far down the rode, Arkansans have a win with the marijuana ballot today.

    The state approved medical marijuana in 2016. In the last couple of years, the has been a grassroots effort to expanded the program. And recently The medical marijuana proposal was aimed at expanding a measure that the state’s voters approved in 2016. It would have broadened the definition of medical professionals who can certify patients for medical cannabis, expanded qualifying conditions and made medical cannabis cards valid for three years.

    In 2023, the state legislature approved and Gov. Sarah Huckabee Sanders signed a bill protecting Arkansas medical cannabis patients’ right to concealed carry of a firearm. The governor leans conservative and has made it clear she is not supportive of the mission.

    The Arkansas Medical Marijuana Amendment would relax regulations. It would allow like  medical professionals other than doctors to sign off on medical marijuana cards, allow patients ages 21 and up to grow and process marijuana plants at home. Additionally it would and open up eligibility for any medical conditions a health care practitioner considers debilitating instead of the existing qualifying conditions.

    Proponents needed to have 90,704 verified votes. Arkansans for Patient Access submitted more than 150,000 signatures.. The state told the group in July it had fallen short of the required number, but had qualified for an additional 30 days to circulate petitions.

    The group said rejecting 20,000 of its signatures was due to an “arbitrary,” last-minute rule change. The state decided to toss enough votes to leave them short 2,664.

    RELATED: Diddy’s Failed Cannabis Investment Saves Industry A Scandal

    But the The Arkansas Supreme Court ruled Wednesday Secretary of State John Thurston must continue verifying signatures to put an amendment loosening medical marijuana laws on the November ballot.  It seems at least 25% will be verified, securing the ballot initiative.

    Arkansas joins states like Florida where Governor DeSantis is working hard to defeats another ballot initiative popular with voters.  November will yield some interesting outcomes.

    [ad_2]

    Terry Hacienda

    Source link

  • Arkansas medical marijuana supporters sue state over decision measure won’t qualify for ballot – Cannabis Business Executive – Cannabis and Marijuana industry news

    Arkansas medical marijuana supporters sue state over decision measure won’t qualify for ballot – Cannabis Business Executive – Cannabis and Marijuana industry news

    [ad_1]





    Arkansas medical marijuana supporters sue state over decision measure won’t qualify for ballot – Cannabis Business Executive – Cannabis and Marijuana industry news




























    skip to Main Content

    [ad_2]

    AggregatedNews

    Source link

  • Santa Saves Cannabis

    Santa Saves Cannabis

    [ad_1]

    As marijuana become legal across North America – the North Pole got caught in fight.

    Canada and a big chunk of the United States have legalized cannabis. The results have been improved medical options, a decrease in alcohol consumption, a reduction of youth use and some more chill people. But the journey to this point has been tough. Opponents have spread misinformation and slowed the process.  Even the current administration has be lackadaisical in the approach. Medical marijuana patients will tell you the benefits in trea tment of chronic pain, cancer, insomnia, inflammation and more. Veterans now have access to treatments to a proven help with PTSD.  It has been a battle, but, in one case, Santa saves Christmas for marijuana fans.

    Thomas O’Connor legally changed his name to Santa Claus in 2005 and is a monk, child welfare activist and local city council member.  He is also a cancer patient and a consumer of medical marijuana.  He resides in North Pole, Alaska, which originally banned all cannabis use.

    RELATED: Science Says Medical Marijuana Improves Quality Of Life

    North Pole, Alaska, a small suburb of Fairbanks, is known for its year-round Christmas decorations, including candy cane–striped street lights. Santa Claus House is a Christmas store with walls covered in children’s letters to Santa and a huge Santa statue outside. Streets have names like Kris Kringle Drive and Mistletoe Lane.  In 2016, the local city council voted to ban marijuana businesses within its city limits. But they didn’t talk to the official leader of the North Pole, Santa Claus.

    Screenshot via WCMH
    When it happened (and it was covered by The Fresh Toast), Santa shared with Alaska’s KTUU. “I think they are not in this particular instance are not embracing the spirit of love. I think what they’re doing is engendering hate, which comes from fear.”

    But you don’t become Santa without having some good will, determination and drive.  Santa worked with the city and city council and managed to get the proposition overturned. Now the area boosts three cannabis dispensaries.

    RELATED: Beer Sales Flatten Thanks To Marijuana

    And Santa? He continues his children welfare advocacy work and, as of 2022, is the mayor pro tem of North Pole. Unfortunately, Santa is still plagued with cancer and continues to be a medical marijuana patient.  We hope more research is in his stocking this year to provide help and relief for him and the millions of patients who would benefit.

    [ad_2]

    Anthony Washington

    Source link

  • Boomer And Gen Z Consume Marijuana For Similar Reasons

    Boomer And Gen Z Consume Marijuana For Similar Reasons

    [ad_1]

    Cannabis has become popular for every adult age group- but the surprise is Gen Z and Boomers are using it for similar reasons.

    Cannabis is fully legal to over 50% of the population and all groups are embracing its use. Proven healthier than alcohol, it has become much more common in all sets. Even Florida looks like it is going to vote for recreational cannabis. Long stigmatized as a way to get high, be lazy and lay about on the couch, it turns out it is become part of every day life…and part of a health regime. An example of how it is being used, Boomer and Gen Z consume marijuana for similar reasons.

    RELATED: The Most Popular Marijuana Flavors

    It is become so accepted, AARP did a study about use among Boomers. AARP is the largest  print magazine with 38 million readers…and their bulletin has 33 million.  A huge validator for the demographic. It also shows they are more open to more mainstream cannabis. This falls in line by the positions of the American Medical Association and the American College of Physicians.

    Photo by Kindel Media from Pexels

    The AARP study revealed 21 percent ages 50-plus used some form of cannabis — be it food, drink, flower or another type— at least once in the last year, a report from the University of Michigan’s National Poll on Healthy Aging found. That’s up from 1 in 8 (12 percent) in 2021. In 2015 and 2016, roughly 3 percent of adults 65 and older used cannabis, according to research published in JAMA Internal Medicine.

    Roughly 68% of poll respondents who used cannabis products did so for help with sleep, the researchers found. Many also cited pain relief (63 percent), mental health, anxiety,  and mood (53 percent) and relaxation (81 percent) as reasons for using cannabis.

    What is interesting is Gen Z, the youngest adult generation, Gen Z, is an also a big fan of marijuana. They helped fuel the California Sober trend where you reduce or stop drinking and use weed instead.  One reason Gen Z has embraced weed is it helps with anxiety and mood.  They also use it for relaxation, way more so than other generation who tend to lean into alcohol.

    RELATED: This Natural Cannabinoid Makes You Feel Happy

    What is interesting is some Boomers and Gen X are consume marijuana in a more traditional way by smoking. Gen X and Boomers new to consuming tend to vape and use gummies.  The later two are more “on the go” and discreet and doesn’t have the smell. It is interesting the marijuana is bonding together two generations.

    [ad_2]

    Amy Hansen

    Source link

  • Key Information About Joint Pain And Medical Marijuana

    Key Information About Joint Pain And Medical Marijuana

    [ad_1]

    Roughly 19% of the people suffer from joint pain – a daily struggle…but here is how medical marijuana can help.

    Roughly 19% suffer from joint pain or some part of arthritis. Not only is it painful, it is disruptive in daily life. Some pain can be short term, like from sprains, an injury, tendinitis, or tendon inflammation, an infection of the bone or joint, or overuse of a joint. But some can be long term issues with an impact the patients like. Arthritis, fibromyalgia, osteoporosis, bursitis, lupus and more can be long, lingering issues with pain. There is some hope, and cannabis might be one.  Here is key information about joint pain and medical marijuana.

    RELATED: What’s Next For Rheumatoid Arthritis And Cannabis?

    One study concluded about 20% of patients with rheumatoid diseases who actively consume cannabis report an improvement in pain. Cannabis contains key components which help reduce inflammation.  More research needs to be done to to perfect treatment and dosage, but early indicators look positive for help. Another current benefit of medical marijuana or CBD with joint pain, is it helps with sleep, which is a problem with people in chronic pain.

    Photo by Ake via rawpixel.com

    Medical marijuana, in the right dose can also be easier on the body. Long used as a natural pain killer, it is less addictive and the body responds positively.  Currently used, orticosteroid injections have been a staple in managing pain and inflammation. With new research showcasing the long-term effects of one of the most used treatments, doctors and researchers are concerned about the risks of injections and the potential risks involved with cortisone. 

    RELATED: Dear Dr. Green: Can Marijuana Topicals Help With Arthritis?

    Boston University study found patients who had been given the medicine by injection found a risk for “accelerated adverse joint events after treatment.” Meaning, when a patient was treated for osteoarthritis or other joint pain via a shot of cortisone, it may have accelerated joint destruction and bone loss. The study also found certain preexisting conditions, such as older age and Caucasian race seemed to increase the risk for the outcome even more. Researchers recommended MRI pre-screening before injections were given to identify the area better and find if the danger could be accurately assessed before the dose was given. 

    Not only can medical marijuana be helpful, but so can CBD. The Arthritis Foundation has a guide to CBD for those that suffer from the condition. According to Dr. Daniel Clauw, a contributor to the guide, “Right now, it (CBD) appears to be fairly safe and might help certain types of pain.” 

    While CBD and THC can be used as part of a pain management regimen, they currently can not be the entire plan. Studies like the one conducted on cortisone treatments are bringing the conversations of cannabis and CBD to greater light and offering less stigmatization, but until more research is done, the best path for joint pain is still unknown.

    [ad_2]

    Amy Hansen

    Source link

  • Nebraska Voters To Decide on Medical Cannabis Access

    Nebraska Voters To Decide on Medical Cannabis Access

    [ad_1]

    Nebraska voters will decide this Election Day on a pair of citizen-initiated ballot measures regulating medical cannabis access to authorized patients.

    State regulators last week affirmed that advocates Nebraskans for Medical Marijuana had gathered the requisite number of signatures to place the measures before voters.

    The two measures are complementary. The first permits qualified patients to possess and use cannabis. The second measure regulates the production and distribution of cannabis to those authorized patients. Advocates had to frame the issue as two separate ballot questions in order to not run afoul of the state’s ‘single subject’ rule. In 2020, the state Supreme Court invalidated a similar stand-alone measure for addressing issues that it deemed were “not naturally and necessarily connected to the [initiative’s] primary purpose.” A 2022 effort failed to obtain sufficient signatures to qualify for the ballot.

    “States have a proven track record of safely and effectively regulating medical marijuana,” NORML’s Deputy Director Paul Armentano said. “After November, Nebraskans will no longer be forced to choose between their medicine or their freedom.”

    Thirty-eight states, the District of Columbia, and several US territories regulate medical cannabis products. Statewide polling indicates that between 70 percent and 80 percent of Nebraskans support legalizing medical marijuana access.

    Nebraska is one of at least four states where cannabis-related initiatives will appear on November’s ballot. Voters in Florida, North Dakota, and South Dakota, who also will be deciding on adult-use legalization measures this fall.

    In Texas, voters in the cities of Bastrop (population 11,200), Dallas (population: 1.3 million), and Lockhart (population 15,000) will decide on municipal ballot measures prohibiting local law enforcement from making low-level marijuana-related arrests.

    Additional Election 2024 coverage is available from NORML.

    [ad_2]

    NORML

    Source link